Innovation Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in the development of therapies with anti-infective, oncology, anti-inflammatory, and dermatology applications. It focuses on its antifungal drug candidate called Brilacidin. The company was founded by Krishna Kumar Menon, George W. Evans, and Leo Ehrlich on June 20, 2007 and is headquartered in Wakefield, MA.